These data overall supported nAChRs, potentially CHRNA4, CHRNB2 and CHRNA3 isoforms, as responsible for nicotine/cotinine’s protective effects in SCLC cells against chemotherapy treatment. This evidence concerns the gene CHRNB2 and small cell lung carcinoma.